VisionCare Ophthalmic Technologies, Inc. announced the expansion of its CentraSight(TM) provider teams nationwide. The telescope implant improves visual acuity and quality of life for those living with the most severe form of AMD and can help seniors become more independent and re-engage in everyday activities. Medicare provides coverage to patients in states across the country for eligible beneficiaries with the most advanced form of age-related macular degeneration -- end-stage AMD. The eye disease is the cause of irreversible vision loss and legal blindness in older Americans. Patients with end-stage AMD have central blindness in both eyes that is uncorrectable by glasses, drugs or cataract surgery.